Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
LKFT

Market Cap: $1.83B

LN

Lakefront Biotherapeutics N.V.

LKFT

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin98.01%

EBITDA Margin45.58%

EBIT Margin45.58%

Pre-tax Margin45.14%

Net Profit Margin46.83%

Earnings Yield30.40%

Valuation Multiples

Price / Book0.49

Price / Sales1.54

Price / Earnings3.29

PEG-0.01

Forward PEG-0.13

EV / Sales1.48

EV / EBITDA3.25

EV / Operating Cash Flow-5.13

EV / Free Cash Flow-4.99

Price / Free Cash Flow-5.18

Price / Operating Cash Flow-5.33

Cash Flow & Capital

Free Cash Flow / Share-$4.71

Operating Cash Flow / Share-$4.58

Free Cash Flow Yield-19.30%

Capex / Revenue0.84%

Capex / Operating Cash Flow-2.90%

Capex / Depreciation0.00

Stock Compensation / Revenue0.00%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio30.48

Quick Ratio30.30

Cash Ratio0.67

Debt / Assets0.00

Debt / Capital0.00

Debt / Equity0.00

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA-0.13

Solvency Ratio4.11

Financial Leverage1.04

Efficiency & Working Capital

Asset Turnover0.31

Fixed Asset Turnover13.56

Inventory Turnover1.18

Receivables Turnover19.32

Payables Turnover0.22

Days Sales Outstanding18.9

Days Inventory Outstanding310.39

Days Payables Outstanding1,680.02

Operating Cycle329.28

Cash Conversion Cycle-1,350.74

Working Capital Turnover0.35

Returns & Quality

Return on Equity16.88%

Return on Assets14.49%

Return on Invested Capital18.22%

ROCE18.23%

Return on Tangible Assets14.50%

Operating Return on Assets17.60%

Income Quality-0.62

Tax Burden1.04

Interest Burden0.99

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.55B

Invested Capital$3.04B

Working Capital$2.96B

Tangible Asset Value$3.25B

Net Current Asset Value$2.94B

Graham Number$90.8

Graham Net-Net$44.21

Book Value / Share$49.39

Tangible Book Value / Share$49.38

Cash / Share$45.27